Your browser doesn't support javascript.
loading
Safety Monitoring Activity During EGFR or Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients With Lung Cancer.
Singh, Avani M; Rubiera-Pebe, Rafael; Ahmad, Yaser; Shafique, Michael; Hicks, J Kevin; Tanvetyanon, Tawee.
Affiliation
  • Singh AM; Division of Hematology and Oncology at H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL.
  • Rubiera-Pebe R; Morsani College of Medicine, University of South Florida, Tampa, FL.
  • Ahmad Y; Morsani College of Medicine, University of South Florida, Tampa, FL.
  • Shafique M; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.
  • Hicks JK; Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.
  • Tanvetyanon T; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.
JCO Oncol Pract ; 19(6): 345-351, 2023 06.
Article in En | MEDLINE | ID: mdl-37075260
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: JCO Oncol Pract Year: 2023 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: JCO Oncol Pract Year: 2023 Type: Article